{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=alone&page=90", "query": { "intervention": "alone", "page": 90 }, "page_size": 10 }, "pagination": { "page": 90, "page_size": 10, "total_count": 35409, "total_pages": 3541, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=alone&page=91&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=alone&page=89&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T08:37:49.443Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07128303", "title": "Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumor" ], "interventions": [ { "name": "GS-5319", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 476, "start_date": "2025-08-28", "completion_date": "2028-05", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 5, "location_summary": "Boston, Massachusetts • New Brunswick, New Jersey • San Antonio, Texas + 1 more", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New Brunswick", "state": "New Jersey" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07128303" }, { "nct_id": "NCT00524303", "title": "Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neoplasms, Breast" ], "interventions": [ { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "FEC75", "type": "DRUG" }, { "name": "Lapatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 100, "start_date": "2007-08", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2016-11-11", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 23, "location_summary": "Fountain Valley, California • Los Angeles, California • Denver, Colorado + 18 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Hudson", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00524303" }, { "nct_id": "NCT03716427", "title": "Drug Interaction Study of CT1812 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "CT1812", "type": "DRUG" }, { "name": "tolbutamide", "type": "DRUG" }, { "name": "dextromethorphan", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cognition Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 16, "start_date": "2016-11-10", "completion_date": "2017-02-15", "has_results": false, "last_update_posted_date": "2018-10-23", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 1, "location_summary": "Kalamazoo, Michigan", "locations": [ { "city": "Kalamazoo", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03716427" }, { "nct_id": "NCT00648986", "title": "Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Brittle Nails" ], "interventions": [ { "name": "Tazorac", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "76 Years", "sex": "ALL", "summary": "18 Years to 76 Years" }, "enrollment_count": 20, "start_date": "2005-08", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2014-07-02", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00648986" }, { "nct_id": "NCT03162783", "title": "A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Syndromes" ], "interventions": [ { "name": "ADX-102 Ophthalmic Solution (0.5%)", "type": "DRUG" }, { "name": "ADX-102 Ophthalmic Solution (0.1%)", "type": "DRUG" }, { "name": "ADX-102 Ophthalmic Lipid Solution (0.5%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aldeyra Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2017-05-15", "completion_date": "2017-07-06", "has_results": true, "last_update_posted_date": "2025-01-16", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 1, "location_summary": "Andover, Massachusetts", "locations": [ { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03162783" }, { "nct_id": "NCT00546741", "title": "Drug Interaction With Metformin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Male and Female Subjects" ], "interventions": [ { "name": "Dapagliflozin", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" }, { "name": "Dapagliflozin + Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 18, "start_date": "2007-11", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2016-12-20", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 1, "location_summary": "Hamilton, New Jersey", "locations": [ { "city": "Hamilton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00546741" }, { "nct_id": "NCT06955741", "title": "A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "BMS-986446 IV", "type": "DRUG" }, { "name": "BMS-986446 SC", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Loratadine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 46, "start_date": "2025-05-05", "completion_date": "2025-09-11", "has_results": false, "last_update_posted_date": "2025-10-01", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 2, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06955741" }, { "nct_id": "NCT03564054", "title": "Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "Photodynamic Therapy", "type": "PROCEDURE" }, { "name": "Argon Plasma Coagulation", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 3, "start_date": "2018-10-11", "completion_date": "2019-09-30", "has_results": false, "last_update_posted_date": "2019-12-18", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03564054" }, { "nct_id": "NCT05634954", "title": "Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "GEH121224 (18F) Injection", "type": "DRUG" }, { "name": "Dynamic and Static - PET/CT Scan", "type": "DIAGNOSTIC_TEST" }, { "name": "Static - PET/CT Scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "GE Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 0, "start_date": "2026-02", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-10-23", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05634954" }, { "nct_id": "NCT02999854", "title": "Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Myelodysplastic Syndrome" ], "interventions": [ { "name": "ATIR101", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "T-cell depleted HSCT from a related, haploidentical donor", "type": "PROCEDURE" }, { "name": "T-cell replete HSCT from a related, haploidentical donor", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE" ], "sponsor": "Kiadis Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 63, "start_date": "2017-11-29", "completion_date": "2021-12-17", "has_results": true, "last_update_posted_date": "2022-05-24", "last_synced_at": "2026-11-13T08:37:49.443Z", "location_count": 12, "location_summary": "Duarte, California • La Jolla, California • Los Angeles, California + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02999854" } ] }